Page last updated: 2024-08-24

fluorodeoxyglucose f18 and rabeprazole

fluorodeoxyglucose f18 has been researched along with rabeprazole in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Domeki, Y; Kato, H; Kitajima, K; Matsuura, A; Murakami, K; Yamazaki, E	1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and rabeprazole

Article	Year
Effects of a proton pump inhibitor on the physiological accumulation of fluoro-2-deoxy-D-glucose (FDG) in FDG-positron emission tomography. Surgery today, 2012, Volume: 42, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Colon; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Proton Pump Inhibitors; Rabeprazole; Radiopharmaceuticals; Stomach; Tissue Distribution; Tomography, X-Ray Computed	2012

Article

Year

Effects of a proton pump inhibitor on the physiological accumulation of fluoro-2-deoxy-D-glucose (FDG) in FDG-positron emission tomography.

Surgery today, 2012, Volume: 42, Issue:10

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Colon; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Proton Pump Inhibitors; Rabeprazole; Radiopharmaceuticals; Stomach; Tissue Distribution; Tomography, X-Ray Computed

2012